New pyrazolo‐[3,4‐ d ]‐pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells
Open Access
- 30 March 2010
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 24 (8), 2881-2892
- https://doi.org/10.1096/fj.09-148593
Abstract
Medulloblastoma is the most common malignant brain tumor in children, and despite improvements in the overall survival rate, it still lacks an effective treatment. Src plays an important role in cancer, and recently high Src activity was documented in medulloblastoma. In this report, we examined the effects of novel pyrazolo-[3,4-d]-pyrirnidine derivative Src inhibitors in medulloblastoma. By MTS assay, we showed that the pyrimidine derivatives indicated as S7, S29, and SI163 greatly reduce the growth rate of medulloblastoma cells by inhibiting Src phosphorylation, compared with HT22 nonneoplastic nerve cells. These compounds also halt cells in the G2/M phase, and this effect likely occurs through the regulation of cdc2 and CDC25C phosphorylation, as shown by Western blot. Moreover, the exposure to pyrimidine derivatives induces apoptosis, assayed by the supravital propidium iodide assay, through modulation of the apoptotic proteins Bax and Bcl2, and inhibits tumor growth in vivo in a mouse model. Notably, S7, S29, and SI163 show major inhibitory effects on medulloblastoma cell growth compared with the chemotherapeutic agents cisplatin and etoposide. In conclusion, our results suggest that S7, S29, and SI163 could be novel attractive candidates for the treatment of medulloblastoma or tumors characterized by high Src activity.—Rossi, A., Schenone, S., Angelucci, A., Cozzi, M., Caracciolo, V., Pentimalli, F., Puca, A., Pucci, B., La Montagna, R., Bologna, M., Botta, M., Giordano, A. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells. FASEB J. 24, 2881–2892 (2010). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health
This publication has 55 references indexed in Scilit:
- Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target DiscoveryCancer Research, 2009
- The decision to enter mitosis: feedback and redundancy in the mitotic entry networkThe Journal of cell biology, 2009
- Inhibition of matrix metalloproteinase‐2 enhances radiosensitivity by abrogating radiation‐induced FoxM1‐mediated G2/M arrest in A549 lung cancer cellsInternational Journal of Cancer, 2009
- The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cellsInternational Journal of Cancer, 2009
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyNature Biotechnology, 2008
- Flexibility and charge asymmetry in the activation loop of Src tyrosine kinasesProteins-Structure Function and Bioinformatics, 2008
- Src Directly Phosphorylates Bif-1 and Prevents Its Interaction with Bax and the Initiation of AnoikisPublished by Elsevier BV ,2008
- Medulloblastoma: From Molecular Pathology to TherapyClinical Cancer Research, 2008
- Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsEuropean Journal of Cancer, 2006
- Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cellsBiochemical Journal, 2001